Exact Mass: 787.5879442

PC(18:0/18:1(9Z))

C44H86NO8P (787.6090726)

PC(18:0/18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:0/18:1(9Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of oleic acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the oleic acid moiety is derived from vegetable oils, especially olive and canola oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(14:0/22:1(13Z))

C44H86NO8P (787.6090726)

PC(14:0/22:1(13Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:0/22:1(13Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of erucic acid at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the erucic acid moiety is derived from seed oils and avocados. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(14:0/22:1(13Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:0/22:1(13Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of erucic acid at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the erucic acid moiety is derived from seed oils and avocados. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PC(14:1(9Z)/22:0)

C44H86NO8P (787.6090726)

PC(14:1(9Z)/22:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:1(9Z)/22:0), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of behenic acid at the C-2 position. The myristoleic acid moiety is derived from milk fats, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(16:0/20:1(11Z))

C44H86NO8P (787.6090726)

PC(16:0/20:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:0/20:1(11Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of eicosenoic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the eicosenoic acid moiety is derived from vegetable oils and cod oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(16:1(9Z)/20:0)

C44H86NO8P (787.6090726)

PC(16:1(9Z)/20:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:1(9Z)/20:0), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of arachidic acid at the C-2 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(18:0/18:1(11Z))

C44H86NO8P (787.6090726)

PC(18:0/18:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:0/18:1(11Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of vaccenic acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the vaccenic acid moiety is derived from butter fat and animal fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(18:1(11Z)/18:0)

C44H86NO8P (787.6090726)

PC(18:1(11Z)/18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(11Z)/18:0), in particular, consists of one chain of vaccenic acid at the C-1 position and one chain of stearic acid at the C-2 position. The vaccenic acid moiety is derived from butter fat and animal fat, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(18:1(11Z)/18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(11Z)/18:0), in particular, consists of one chain of vaccenic acid at the C-1 position and one chain of stearic acid at the C-2 position. The vaccenic acid moiety is derived from butter fat and animal fat, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PC(18:1(9Z)/18:0)

C44H86NO8P (787.6090726)

PC(18:1(9Z)/18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(9Z)/18:0), in particular, consists of one chain of oleic acid at the C-1 position and one chain of stearic acid at the C-2 position. The oleic acid moiety is derived from vegetable oils, especially olive and canola oil, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(18:1(9Z)/18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(9Z)/18:0), in particular, consists of one chain of oleic acid at the C-1 position and one chain of stearic acid at the C-2 position. The oleic acid moiety is derived from vegetable oils, especially olive and canola oil, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PC(20:0/16:1(9Z))

C44H86NO8P (787.6090726)

PC(20:0/16:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:0/16:1(9Z)), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. The arachidic acid moiety is derived from peanut oil, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(20:1(11Z)/16:0)

C44H86NO8P (787.6090726)

PC(20:1(11Z)/16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:1(11Z)/16:0), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The eicosenoic acid moiety is derived from vegetable oils and cod oils, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(22:0/14:1(9Z))

C44H86NO8P (787.6090726)

PC(22:0/14:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:0/14:1(9Z)), in particular, consists of one chain of behenic acid at the C-1 position and one chain of myristoleic acid at the C-2 position. The behenic acid moiety is derived from groundnut oil, while the myristoleic acid moiety is derived from milk fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(22:1(13Z)/14:0)

C44H86NO8P (787.6090726)

PC(22:1(13Z)/14:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:1(13Z)/14:0), in particular, consists of one chain of erucic acid at the C-1 position and one chain of myristic acid at the C-2 position. The erucic acid moiety is derived from seed oils and avocados, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PE(15:0/24:1(15Z))

C44H86NO8P (787.6090726)

PE(15:0/24:1(15Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(15:0/24:1(15Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of nervonic acid at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the nervonic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(15:0/24:1(15Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(15:0/24:1(15Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of nervonic acid at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the nervonic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE(24:1(15Z)/15:0)

C44H86NO8P (787.6090726)

PE(24:1(15Z)/15:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(24:1(15Z)/15:0), in particular, consists of one chain of nervonic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The nervonic acid moiety is derived from fish oils, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PE-NMe(14:0/24:1(15Z))

C44H86NO8P (787.6090726)

PE-NMe(14:0/24:1(15Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(14:0/24:1(15Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of nervonic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(14:1(9Z)/24:0)

C44H86NO8P (787.6090726)

PE-NMe(14:1(9Z)/24:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(14:1(9Z)/24:0), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of lignoceric acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(16:0/22:1(13Z))

C44H86NO8P (787.6090726)

PE-NMe(16:0/22:1(13Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(16:0/22:1(13Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of erucic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(16:1(9Z)/22:0)

C44H86NO8P (787.6090726)

PE-NMe(16:1(9Z)/22:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(16:1(9Z)/22:0), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of behenic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(18:0/20:1(11Z))

C44H86NO8P (787.6090726)

PE-NMe(18:0/20:1(11Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(18:0/20:1(11Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of eicosenoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(18:1(11Z)/20:0)

C44H86NO8P (787.6090726)

PE-NMe(18:1(11Z)/20:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(18:1(11Z)/20:0), in particular, consists of one chain of cis-vaccenic acid at the C-1 position and one chain of arachidic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(18:1(9Z)/20:0)

C44H86NO8P (787.6090726)

PE-NMe(18:1(9Z)/20:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(18:1(9Z)/20:0), in particular, consists of one chain of oleic acid at the C-1 position and one chain of arachidic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(20:0/18:1(11Z))

C44H86NO8P (787.6090726)

PE-NMe(20:0/18:1(11Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(20:0/18:1(11Z)), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of cis-vaccenic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(20:0/18:1(9Z))

C44H86NO8P (787.6090726)

PE-NMe(20:0/18:1(9Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(20:0/18:1(9Z)), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of oleic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(20:1(11Z)/18:0)

C44H86NO8P (787.6090726)

PE-NMe(20:1(11Z)/18:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(20:1(11Z)/18:0), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of stearic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(22:0/16:1(9Z))

C44H86NO8P (787.6090726)

PE-NMe(22:0/16:1(9Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(22:0/16:1(9Z)), in particular, consists of one chain of behenic acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(22:1(13Z)/16:0)

C44H86NO8P (787.6090726)

PE-NMe(22:1(13Z)/16:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(22:1(13Z)/16:0), in particular, consists of one chain of erucic acid at the C-1 position and one chain of palmitic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(24:0/14:1(9Z))

C44H86NO8P (787.6090726)

PE-NMe(24:0/14:1(9Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(24:0/14:1(9Z)), in particular, consists of one chain of lignoceric acid at the C-1 position and one chain of myristoleic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(24:1(15Z)/14:0)

C44H86NO8P (787.6090726)

PE-NMe(24:1(15Z)/14:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(24:1(15Z)/14:0), in particular, consists of one chain of nervonic acid at the C-1 position and one chain of myristic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(15:0/22:1(13Z))

C44H86NO8P (787.6090726)

PE-NMe2(15:0/22:1(13Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(15:0/22:1(13Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of erucic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(22:1(13Z)/15:0)

C44H86NO8P (787.6090726)

PE-NMe2(22:1(13Z)/15:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(22:1(13Z)/15:0), in particular, consists of one chain of erucic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE(20:0/18:1(12Z)-O(9S,10R))

C43H82NO9P (787.5726892)

PE(20:0/18:1(12Z)-O(9S,10R)) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(20:0/18:1(12Z)-O(9S,10R)), in particular, consists of one chain of one eicosanoyl at the C-1 position and one chain of 9,10-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

PE(18:1(12Z)-O(9S,10R)/20:0)

C43H82NO9P (787.5726892)

PE(18:1(12Z)-O(9S,10R)/20:0) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(18:1(12Z)-O(9S,10R)/20:0), in particular, consists of one chain of one 9,10-epoxy-octadecenoyl at the C-1 position and one chain of eicosanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

PE(20:0/18:1(9Z)-O(12,13))

C43H82NO9P (787.5726892)

PE(20:0/18:1(9Z)-O(12,13)) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(20:0/18:1(9Z)-O(12,13)), in particular, consists of one chain of one eicosanoyl at the C-1 position and one chain of 12,13-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

PE(18:1(9Z)-O(12,13)/20:0)

C43H82NO9P (787.5726892)

PE(18:1(9Z)-O(12,13)/20:0) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(18:1(9Z)-O(12,13)/20:0), in particular, consists of one chain of one 12,13-epoxy-octadecenoyl at the C-1 position and one chain of eicosanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

PC(17:0/18:1(12Z)-O(9S,10R))

C43H82NO9P (787.5726892)

PC(17:0/18:1(12Z)-O(9S,10R)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(17:0/18:1(12Z)-O(9S,10R)), in particular, consists of one chain of one heptadecanoyl at the C-1 position and one chain of 9,10-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(18:1(12Z)-O(9S,10R)/17:0)

C43H82NO9P (787.5726892)

PC(18:1(12Z)-O(9S,10R)/17:0) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(18:1(12Z)-O(9S,10R)/17:0), in particular, consists of one chain of one 9,10-epoxy-octadecenoyl at the C-1 position and one chain of heptadecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(17:0/18:1(9Z)-O(12,13))

C43H82NO9P (787.5726892)

PC(17:0/18:1(9Z)-O(12,13)) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(17:0/18:1(9Z)-O(12,13)), in particular, consists of one chain of one heptadecanoyl at the C-1 position and one chain of 12,13-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(18:1(9Z)-O(12,13)/17:0)

C43H82NO9P (787.5726892)

PC(18:1(9Z)-O(12,13)/17:0) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(18:1(9Z)-O(12,13)/17:0), in particular, consists of one chain of one 12,13-epoxy-octadecenoyl at the C-1 position and one chain of heptadecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

Astrocerebroside B

C44H85NO10 (787.617315)

Phosphatidylcholine 18:0-18:1

C44H86NO8P (787.6090726)

Phosphatidylserine 18:0-18:1

C43H82NO9P (787.5726892)

PRECURSOR_TYPE [M-H]-/[M-Ser]-

PC(17:0/9-HODE)

C43H82NO9P (787.5726892)

Acanthacerebroside C

C44H85NO10 (787.617315)

PC 36:1

C44H86NO8P (787.6090726)

Found in mouse brain; TwoDicalId=66; MgfFile=160720_brain_EPA_08_Neg; MgfId=1487

trimethyl(2-{[2-[octadec-9-enoyloxy]-3-(octadecanoyloxy)propyl phosphono]oxy}ethyl)azanium

C44H86NO8P (787.6090726)

PC 18:0/18:1(9Z)

C44H86NO8P (787.6090726)

FRAGMENTATION_MODE is Hydrogen Abstraction Dissociation (HAD); MALDI generates [M+H]+ ion, which is dissociated by the reaction with hydrogen radical (H*) generated by microwave-driven radical generator.; This mass spectral data is shown in Figure 1(B) of the publication.; The instrument consists of QIT-TOF where Q selects [M+H]+ ion, IT is an ion trap chamber for the reaction of HAD, and TOF analyzes the product ions.; The sample was injected by direct infusion of methanol solution.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 19HP8024 to the Mass Spectrometry Society of Japan.; The lipid standard was purchased from Avanti Polar Lipids (Alabaster, AL).

PC(16:0/20:1)[U]

C44H86NO8P (787.6090726)

PC(18:0/18:1)[U]

C44H86NO8P (787.6090726)

PC(18:0/18:1)

C44H86NO8P (787.6090726)

PC(18:0/18:1)[S]

C44H86NO8P (787.6090726)

PC(18:1/18:0)[U]

C44H86NO8P (787.6090726)

PC(20:1/16:0)[U]

C44H86NO8P (787.6090726)

1-(6-[3]-ladderane-hexanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine

C46H78NO7P (787.5515607999998)

Lecithin

C44H86NO8P (787.6090726)

PE(39:1)

C44H86NO8P (787.6090726)

PC(14:0/22:1(11Z))

C44H86NO8P (787.6090726)

PC(15:1(9Z)/21:0)

C44H86NO8P (787.6090726)

PC(17:0/19:1(9Z))

C44H86NO8P (787.6090726)

PC(17:1(9Z)/19:0)

C44H86NO8P (787.6090726)

PC(19:0/17:1(9Z))

C44H86NO8P (787.6090726)

PC(19:1(9Z)/17:0)

C44H86NO8P (787.6090726)

PC(21:0/15:1(9Z))

C44H86NO8P (787.6090726)

PC(22:1(11Z)/14:0)

C44H86NO8P (787.6090726)

PE(17:0/22:1(11Z))

C44H86NO8P (787.6090726)

PE(17:1(9Z)/22:0)

C44H86NO8P (787.6090726)

PE(18:1(9Z)/21:0)

C44H86NO8P (787.6090726)

PE(19:0/20:1(11Z))

C44H86NO8P (787.6090726)

PE(19:1(9Z)/20:0)

C44H86NO8P (787.6090726)

PE(20:0/19:1(9Z))

C44H86NO8P (787.6090726)

PE(20:1(11Z)/19:0)

C44H86NO8P (787.6090726)

PE(21:0/18:1(9Z))

C44H86NO8P (787.6090726)

PE(22:0/17:1(9Z))

C44H86NO8P (787.6090726)

PE(22:1(11Z)/17:0)

C44H86NO8P (787.6090726)

PS(O-20:0/17:2(9Z,12Z))

C43H82NO9P (787.5726892)

PS(P-18:0/19:1(9Z))

C43H82NO9P (787.5726892)

PS(P-20:0/17:1(9Z))

C43H82NO9P (787.5726892)

PC O-38:8

C46H78NO7P (787.5515607999998)

PE 39:1

C44H86NO8P (787.6090726)

PS O-37:2

C43H82NO9P (787.5726892)

HexCer 38:1;O4

C44H85NO10 (787.617315)

Lytixar

C43H69N11O3 (787.5584564)

C254 - Anti-Infective Agent > C52588 - Antibacterial Agent

1-Steroyl-2-oleoylphosphatidylcholine

C44H86NO8P (787.6090726)

PE-NMe(16:0/22:1(13Z))

C44H86NO8P (787.6090726)

PE(20:0/18:1(12Z)-O(9S,10R))

C43H82NO9P (787.5726892)

PE(18:1(12Z)-O(9S,10R)/20:0)

C43H82NO9P (787.5726892)

PC(17:0/18:1(12Z)-O(9S,10R))

C43H82NO9P (787.5726892)

PC(18:1(12Z)-O(9S,10R)/17:0)

C43H82NO9P (787.5726892)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxypropyl] icosanoate

C43H82NO9P (787.5726892)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxypropan-2-yl] icosanoate

C43H82NO9P (787.5726892)

[(2R)-3-heptadecanoyloxy-2-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H82NO9P (787.5726892)

[(2R)-2-heptadecanoyloxy-3-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H82NO9P (787.5726892)

2-[[(E,2S,3R)-2-[[(E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoyl]amino]-3-hydroxyheptadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C42H80N2O9P+ (787.5601140000001)

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoylamino]heptadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C42H80N2O9P+ (787.5601140000001)

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[7-[(1R,2R,5S)-5-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-3-oxocyclopentyl]heptanoylamino]heptadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C42H80N2O9P+ (787.5601140000001)

2-[[(2S,3R,4E,8Z)-2-[7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]heptanoylamino]-3-hydroxyheptadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C42H80N2O9P+ (787.5601140000001)

2-[[(2S,3R)-2-[[(8Z,11Z,14Z)-5,6-dihydroxyicosa-8,11,14-trienoyl]amino]-3-hydroxyoctadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O8P+ (787.5964974000001)

2-[[(E,2S,3R)-2-[[(Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(E,3R)-3-hydroxyoct-1-enyl]cyclopentyl]pent-3-enoyl]amino]-3-hydroxynonadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C42H80N2O9P+ (787.5601140000001)

[3-hexadecanoyloxy-2-[(Z)-icos-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

HexCer 9:1;2O/32:5

C47H81NO8 (787.5961866)

HexCer 9:0;2O/32:6

C47H81NO8 (787.5961866)

HexCer 23:1;2O/18:5

C47H81NO8 (787.5961866)

HexCer 19:2;2O/22:4

C47H81NO8 (787.5961866)

HexCer 25:2;2O/16:4

C47H81NO8 (787.5961866)

HexCer 11:1;2O/30:5

C47H81NO8 (787.5961866)

HexCer 17:1;2O/24:5

C47H81NO8 (787.5961866)

HexCer 21:1;2O/20:5

C47H81NO8 (787.5961866)

HexCer 13:0;2O/28:6

C47H81NO8 (787.5961866)

HexCer 11:0;2O/30:6

C47H81NO8 (787.5961866)

HexCer 25:3;2O/16:3

C47H81NO8 (787.5961866)

HexCer 19:3;2O/22:3

C47H81NO8 (787.5961866)

HexCer 13:1;2O/28:5

C47H81NO8 (787.5961866)

HexCer 15:3;2O/26:3

C47H81NO8 (787.5961866)

HexCer 17:0;2O/24:6

C47H81NO8 (787.5961866)

HexCer 15:2;2O/26:4

C47H81NO8 (787.5961866)

HexCer 15:0;2O/26:6

C47H81NO8 (787.5961866)

HexCer 15:1;2O/26:5

C47H81NO8 (787.5961866)

HexCer 21:2;2O/20:4

C47H81NO8 (787.5961866)

HexCer 23:2;2O/18:4

C47H81NO8 (787.5961866)

HexCer 19:1;2O/22:5

C47H81NO8 (787.5961866)

HexCer 21:3;2O/20:3

C47H81NO8 (787.5961866)

HexCer 23:3;2O/18:3

C47H81NO8 (787.5961866)

HexCer 17:2;2O/24:4

C47H81NO8 (787.5961866)

HexCer 19:0;2O/22:6

C47H81NO8 (787.5961866)

HexCer 17:3;2O/24:3

C47H81NO8 (787.5961866)

HexCer 13:2;2O/28:4

C47H81NO8 (787.5961866)

2-[3-nonanoyloxy-2-[(13Z,16Z,19Z,22Z,25Z)-octacosa-13,16,19,22,25-pentaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C47H81NO8 (787.5961866)

Lnape 15:0/N-24:1

C44H86NO8P (787.6090726)

Lnape 16:1/N-23:0

C44H86NO8P (787.6090726)

Lnape 24:1/N-15:0

C44H86NO8P (787.6090726)

Lnape 20:1/N-19:0

C44H86NO8P (787.6090726)

Lnape 13:1/N-26:0

C44H86NO8P (787.6090726)

Lnape 21:1/N-18:0

C44H86NO8P (787.6090726)

Lnape 13:0/N-26:1

C44H86NO8P (787.6090726)

Lnape 18:0/N-21:1

C44H86NO8P (787.6090726)

Lnape 15:1/N-24:0

C44H86NO8P (787.6090726)

Lnape 20:0/N-19:1

C44H86NO8P (787.6090726)

Lnape 21:0/N-18:1

C44H86NO8P (787.6090726)

Lnape 19:0/N-20:1

C44H86NO8P (787.6090726)

Lnape 18:1/N-21:0

C44H86NO8P (787.6090726)

Lnape 17:1/N-22:0

C44H86NO8P (787.6090726)

Lnape 19:1/N-20:0

C44H86NO8P (787.6090726)

Lnape 24:0/N-15:1

C44H86NO8P (787.6090726)

Lnape 14:1/N-25:0

C44H86NO8P (787.6090726)

Lnape 17:0/N-22:1

C44H86NO8P (787.6090726)

Lnape 26:1/N-13:0

C44H86NO8P (787.6090726)

Lnape 22:1/N-17:0

C44H86NO8P (787.6090726)

Lnape 22:0/N-17:1

C44H86NO8P (787.6090726)

Lnape 25:0/N-14:1

C44H86NO8P (787.6090726)

Lnape 26:0/N-13:1

C44H86NO8P (787.6090726)

Lnape 23:0/N-16:1

C44H86NO8P (787.6090726)

2-[2-[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]oxy-3-tridecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C47H81NO8 (787.5961866)

2-[3-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C47H81NO8 (787.5961866)

2-[3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C47H81NO8 (787.5961866)

2-[3-heptadecanoyloxy-2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C47H81NO8 (787.5961866)

2-[3-nonadecanoyloxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C47H81NO8 (787.5961866)

2-[3-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C47H81NO8 (787.5961866)

2-[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-pentadecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C47H81NO8 (787.5961866)

2-[3-[(Z)-heptadec-9-enoyl]oxy-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C47H81NO8 (787.5961866)

2-[3-[(Z)-nonadec-9-enoyl]oxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C47H81NO8 (787.5961866)

2-[2-[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]oxy-3-undecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C47H81NO8 (787.5961866)

2-[3-[(Z)-henicos-11-enoyl]oxy-2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C47H81NO8 (787.5961866)

2-[2-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C47H81NO8 (787.5961866)

2-[2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C47H81NO8 (787.5961866)

HexCer 9:0;3O/29:1;(2OH)

C44H85NO10 (787.617315)

HexCer 8:0;3O/30:1;(2OH)

C44H85NO10 (787.617315)

HexCer 13:0;3O/25:1;(2OH)

C44H85NO10 (787.617315)

HexCer 12:1;3O/26:0;(2OH)

C44H85NO10 (787.617315)

HexCer 10:0;3O/28:1;(2OH)

C44H85NO10 (787.617315)

HexCer 12:0;3O/26:1;(2OH)

C44H85NO10 (787.617315)

HexCer 13:1;3O/25:0;(2OH)

C44H85NO10 (787.617315)

HexCer 11:0;3O/27:1;(2OH)

C44H85NO10 (787.617315)

(E)-2-[[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]amino]-3-hydroxydocos-4-ene-1-sulfonic acid

C48H85NO5S (787.6148119999999)

(4E,8E,12E)-2-[[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]amino]-3-hydroxyhexacosa-4,8,12-triene-1-sulfonic acid

C48H85NO5S (787.6148119999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoxy]propan-2-yl] (Z)-tridec-9-enoate

C46H78NO7P (787.5515607999998)

(4E,8E,12E)-2-[[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]amino]-3-hydroxydocosa-4,8,12-triene-1-sulfonic acid

C48H85NO5S (787.6148119999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] (7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoate

C46H78NO7P (787.5515607999998)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] (5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoate

C46H78NO7P (787.5515607999998)

(E)-2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxyhexacos-4-ene-1-sulfonic acid

C48H85NO5S (787.6148119999999)

(4E,8E)-2-[[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]amino]-3-hydroxyhexacosa-4,8-diene-1-sulfonic acid

C48H85NO5S (787.6148119999999)

(4E,8E,12E)-3-hydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]tetracosa-4,8,12-triene-1-sulfonic acid

C48H85NO5S (787.6148119999999)

3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]amino]tetracosane-1-sulfonic acid

C48H85NO5S (787.6148119999999)

2-[[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-3-hydroxyhexacosane-1-sulfonic acid

C48H85NO5S (787.6148119999999)

(4E,8E)-3-hydroxy-2-[[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]amino]tetracosa-4,8-diene-1-sulfonic acid

C48H85NO5S (787.6148119999999)

(E)-3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]tetracos-4-ene-1-sulfonic acid

C48H85NO5S (787.6148119999999)

2-[[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoyl]amino]-3-hydroxydocosane-1-sulfonic acid

C48H85NO5S (787.6148119999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoxy]propan-2-yl] (Z)-pentadec-9-enoate

C46H78NO7P (787.5515607999998)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

C46H78NO7P (787.5515607999998)

(4E,8E)-2-[[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]amino]-3-hydroxydocosa-4,8-diene-1-sulfonic acid

C48H85NO5S (787.6148119999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-heptadeca-9,12-dienoxy]propan-2-yl] (6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoate

C46H78NO7P (787.5515607999998)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoxy]propan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C46H78NO7P (787.5515607999998)

2-amino-3-[hydroxy-[3-[(Z)-tetracos-13-enoxy]-2-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid

C43H82NO9P (787.5726892)

2-amino-3-[hydroxy-[2-[(Z)-nonadec-9-enoyl]oxy-3-[(Z)-octadec-9-enoxy]propoxy]phosphoryl]oxypropanoic acid

C43H82NO9P (787.5726892)

2-amino-3-[[2-[(15Z,18Z)-hexacosa-15,18-dienoyl]oxy-3-undecoxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C43H82NO9P (787.5726892)

2-amino-3-[[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-pentadecoxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C43H82NO9P (787.5726892)

2-amino-3-[hydroxy-[3-[(13Z,16Z)-tetracosa-13,16-dienoxy]-2-tridecanoyloxypropoxy]phosphoryl]oxypropanoic acid

C43H82NO9P (787.5726892)

[2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxy-3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H78NO7P (787.5515607999998)

2-amino-3-[hydroxy-[3-[(9Z,12Z)-nonadeca-9,12-dienoxy]-2-octadecanoyloxypropoxy]phosphoryl]oxypropanoic acid

C43H82NO9P (787.5726892)

2-amino-3-[hydroxy-[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-octadecoxypropoxy]phosphoryl]oxypropanoic acid

C43H82NO9P (787.5726892)

2-amino-3-[[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-icosoxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C43H82NO9P (787.5726892)

2-amino-3-[[3-[(Z)-henicos-11-enoxy]-2-[(Z)-hexadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C43H82NO9P (787.5726892)

2-amino-3-[[2-henicosanoyloxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

C43H82NO9P (787.5726892)

2-amino-3-[[3-henicosoxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C43H82NO9P (787.5726892)

2-amino-3-[hydroxy-[2-nonadecanoyloxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propoxy]phosphoryl]oxypropanoic acid

C43H82NO9P (787.5726892)

[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H78NO7P (787.5515607999998)

2-amino-3-[[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-hexadecoxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C43H82NO9P (787.5726892)

2-amino-3-[hydroxy-[2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxy-3-tridecoxypropoxy]phosphoryl]oxypropanoic acid

C43H82NO9P (787.5726892)

2-amino-3-[[3-heptadecoxy-2-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C43H82NO9P (787.5726892)

2-amino-3-[[2-[(Z)-henicos-11-enoyl]oxy-3-[(Z)-hexadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

C43H82NO9P (787.5726892)

2-amino-3-[hydroxy-[2-[(Z)-tetracos-13-enoyl]oxy-3-[(Z)-tridec-9-enoxy]propoxy]phosphoryl]oxypropanoic acid

C43H82NO9P (787.5726892)

2-amino-3-[[3-[(15Z,18Z)-hexacosa-15,18-dienoxy]-2-undecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C43H82NO9P (787.5726892)

2-amino-3-[[2-[(Z)-heptadec-9-enoyl]oxy-3-[(Z)-icos-11-enoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

C43H82NO9P (787.5726892)

2-amino-3-[hydroxy-[3-nonadecoxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropoxy]phosphoryl]oxypropanoic acid

C43H82NO9P (787.5726892)

2-amino-3-[[3-[(13Z,16Z)-docosa-13,16-dienoxy]-2-pentadecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C43H82NO9P (787.5726892)

2-amino-3-[[3-[(Z)-heptadec-9-enoxy]-2-[(Z)-icos-11-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C43H82NO9P (787.5726892)

2-amino-3-[[3-[(Z)-docos-13-enoxy]-2-[(Z)-pentadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C43H82NO9P (787.5726892)

2-amino-3-[[3-[(11Z,14Z)-henicosa-11,14-dienoxy]-2-hexadecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C43H82NO9P (787.5726892)

2-amino-3-[hydroxy-[3-[(Z)-nonadec-9-enoxy]-2-[(Z)-octadec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid

C43H82NO9P (787.5726892)

2-amino-3-[[2-[(Z)-docos-13-enoyl]oxy-3-[(Z)-pentadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

C43H82NO9P (787.5726892)

2-amino-3-[[3-[(9Z,12Z)-heptadeca-9,12-dienoxy]-2-icosanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C43H82NO9P (787.5726892)

2-amino-3-[[2-heptadecanoyloxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

C43H82NO9P (787.5726892)

2-[4-[12-hydroxy-10,13-dimethyl-3-[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]oxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]acetic acid

C50H77NO6 (787.5750582000001)

2-[4-[3-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]ethanesulfonic acid

C47H81NO6S (787.5784286)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (Z)-octacos-17-enoate

C44H86NO8P (787.6090726)

Cer 16:0;2O/16:5;(3OH)(FA 19:5)

C51H81NO5 (787.6114415999999)

Cer 16:0;2O/19:5;(3OH)(FA 16:5)

C51H81NO5 (787.6114415999999)

Cer 19:0;2O/16:5;(3OH)(FA 16:5)

C51H81NO5 (787.6114415999999)

Cer 15:0;2O/20:5;(3OH)(FA 16:5)

C51H81NO5 (787.6114415999999)

Cer 15:0;2O/18:5;(3OH)(FA 18:5)

C51H81NO5 (787.6114415999999)

Cer 14:0;2O/19:5;(3OH)(FA 18:5)

C51H81NO5 (787.6114415999999)

Cer 15:0;2O/20:6;(3OH)(FA 16:4)

C51H81NO5 (787.6114415999999)

Cer 17:0;2O/16:5;(3OH)(FA 18:5)

C51H81NO5 (787.6114415999999)

Cer 14:0;2O/18:5;(3OH)(FA 19:5)

C51H81NO5 (787.6114415999999)

Cer 17:0;2O/18:5;(3OH)(FA 16:5)

C51H81NO5 (787.6114415999999)

Cer 14:0;2O/21:5;(3OH)(FA 16:5)

C51H81NO5 (787.6114415999999)

Cer 15:0;2O/16:5;(3OH)(FA 20:5)

C51H81NO5 (787.6114415999999)

Cer 14:0;2O/16:5;(3OH)(FA 21:5)

C51H81NO5 (787.6114415999999)

Cer 15:0;2O/16:4;(3OH)(FA 20:6)

C51H81NO5 (787.6114415999999)

OxPE 38:3e+2O

C43H82NO9P (787.5726892)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoxy]propan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

C46H78NO7P (787.5515607999998)

Lpc 38:8-SN1

C46H78NO7P (787.5515607999998)

[2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H78NO7P (787.5515607999998)

HexCer 23:1;3O/15:0;(2OH)

C44H85NO10 (787.617315)

HexCer 22:1;3O/16:0;(2OH)

C44H85NO10 (787.617315)

HexCer 24:0;3O/14:1;(2OH)

C44H85NO10 (787.617315)

HexCer 17:0;3O/21:1;(2OH)

C44H85NO10 (787.617315)

HexCer 21:1;3O/17:0;(2OH)

C44H85NO10 (787.617315)

HexCer 15:1;3O/23:0;(2OH)

C44H85NO10 (787.617315)

HexCer 14:0;3O/24:1;(2OH)

C44H85NO10 (787.617315)

HexCer 26:0;3O/12:1;(2OH)

C44H85NO10 (787.617315)

HexCer 22:0;3O/16:1;(2OH)

C44H85NO10 (787.617315)

HexCer 14:1;3O/24:0;(2OH)

C44H85NO10 (787.617315)

HexCer 19:1;3O/19:0;(2OH)

C44H85NO10 (787.617315)

HexCer 20:1;3O/18:0;(2OH)

C44H85NO10 (787.617315)

HexCer 25:0;3O/13:1;(2OH)

C44H85NO10 (787.617315)

HexCer 24:1;3O/14:0;(2OH)

C44H85NO10 (787.617315)

HexCer 19:0;3O/19:1;(2OH)

C44H85NO10 (787.617315)

HexCer 18:0;3O/20:1;(2OH)

C44H85NO10 (787.617315)

HexCer 26:1;3O/12:0;(2OH)

C44H85NO10 (787.617315)

HexCer 17:1;3O/21:0;(2OH)

C44H85NO10 (787.617315)

HexCer 16:0;3O/22:1;(2OH)

C44H85NO10 (787.617315)

HexCer 23:0;3O/15:1;(2OH)

C44H85NO10 (787.617315)

HexCer 18:1;3O/20:0;(2OH)

C44H85NO10 (787.617315)

HexCer 16:1;3O/22:0;(2OH)

C44H85NO10 (787.617315)

HexCer 20:0;3O/18:1;(2OH)

C44H85NO10 (787.617315)

HexCer 25:1;3O/13:0;(2OH)

C44H85NO10 (787.617315)

HexCer 15:0;3O/23:1;(2OH)

C44H85NO10 (787.617315)

[3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H78NO7P (787.5515607999998)

[3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoxy]-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H78NO7P (787.5515607999998)

[3-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoxy]-2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C46H78NO7P (787.5515607999998)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] (Z)-triacont-19-enoate

C44H86NO8P (787.6090726)

[2-[(Z)-octacos-17-enoyl]oxy-3-octanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-tridec-9-enoyl]oxypropyl] hexacosanoate

C44H86NO8P (787.6090726)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] pentacosanoate

C44H86NO8P (787.6090726)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonadecanoyloxypropan-2-yl] (Z)-icos-11-enoate

C44H86NO8P (787.6090726)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (Z)-docos-13-enoate

C44H86NO8P (787.6090726)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-hexadec-9-enoyl]oxypropyl] tricosanoate

C44H86NO8P (787.6090726)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] tetracosanoate

C44H86NO8P (787.6090726)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-heptadec-9-enoyl]oxypropyl] docosanoate

C44H86NO8P (787.6090726)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (Z)-hexacos-15-enoate

C44H86NO8P (787.6090726)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (Z)-tetracos-13-enoate

C44H86NO8P (787.6090726)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-nonadec-9-enoyl]oxypropyl] icosanoate

C44H86NO8P (787.6090726)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecanoyloxypropan-2-yl] (Z)-henicos-11-enoate

C44H86NO8P (787.6090726)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-octadec-9-enoyl]oxypropyl] henicosanoate

C44H86NO8P (787.6090726)

[2-[(Z)-hexadec-9-enoyl]oxy-3-icosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[3-[(2-amino-3-oxobutoxy)-hydroxyphosphoryl]oxy-2-[(Z)-octadec-4-enoyl]oxypropyl] octadecanoate

C43H82NO9P (787.5726892)

[3-dodecanoyloxy-2-[(Z)-tetracos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[2-[(Z)-heptadec-9-enoyl]oxy-3-nonadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[2-[(9Z,11E)-13-hydroxyoctadeca-9,11-dienoyl]oxy-3-octadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[3-decanoyloxy-2-[(Z)-hexacos-15-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[2-[(E)-10-hydroxyoctadec-12-enoyl]oxy-3-[(Z)-octadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[2-[10-(3-hexyloxiran-2-yl)decanoyloxy]-3-[(Z)-octadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[2-[(Z)-docos-13-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[3-octadecoxy-2-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[3-tricosanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[3-docosanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[2-[(Z)-henicos-11-enoyl]oxy-3-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[3-heptadecanoyloxy-2-[(Z)-nonadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[3-henicosanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

(5E,8E,11E,14E)-N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptadeca-4,8-dien-2-yl]tetracosa-5,8,11,14-tetraenamide

C47H81NO8 (787.5961866)

[(2R)-3-decanoyloxy-2-[(E)-hexacos-5-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[(2R)-2-octadecanoyloxy-3-[(E)-octadec-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[(2R)-3-octadecanoyloxy-2-[(E)-octadec-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-13-enoyl]oxypropyl] henicosanoate

C44H86NO8P (787.6090726)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-tetradec-9-enoyl]oxypropyl] pentacosanoate

C44H86NO8P (787.6090726)

[(2R)-3-[(E)-heptadec-9-enoyl]oxy-2-nonadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (E)-tetracos-15-enoate

C44H86NO8P (787.6090726)

[(2R)-2-[(E)-heptadec-9-enoyl]oxy-3-nonadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonadecanoyloxypropan-2-yl] (E)-icos-11-enoate

C44H86NO8P (787.6090726)

[(2R)-2-octadecanoyloxy-3-[(E)-octadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (E)-docos-13-enoate

C44H86NO8P (787.6090726)

[(2R)-2-hexadecanoyloxy-3-[(E)-icos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[(2R)-2-octadecanoyloxy-3-[(E)-octadec-6-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-nonadecanoyloxypropyl] (E)-icos-13-enoate

C44H86NO8P (787.6090726)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-pentadecanoyloxypropyl] (E)-tetracos-15-enoate

C44H86NO8P (787.6090726)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-6-enoyl]oxypropan-2-yl] henicosanoate

C44H86NO8P (787.6090726)

[(2R)-2-octadecanoyloxy-3-[(E)-octadec-4-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-hexadec-9-enoyl]oxypropyl] tricosanoate

C44H86NO8P (787.6090726)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-pentadec-9-enoyl]oxypropyl] tetracosanoate

C44H86NO8P (787.6090726)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-7-enoyl]oxypropan-2-yl] tricosanoate

C44H86NO8P (787.6090726)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-heptadec-9-enoyl]oxypropyl] docosanoate

C44H86NO8P (787.6090726)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tridecanoyloxypropyl] (E)-hexacos-5-enoate

C44H86NO8P (787.6090726)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-octadec-17-enoyloxypropyl] henicosanoate

C44H86NO8P (787.6090726)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-pentadec-9-enoyl]oxypropan-2-yl] tetracosanoate

C44H86NO8P (787.6090726)

[(2R)-2-[(E)-docos-13-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-9-enoyl]oxypropan-2-yl] tricosanoate

C44H86NO8P (787.6090726)

[(2R)-3-octadecanoyloxy-2-[(E)-octadec-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[(2R)-3-dodecanoyloxy-2-[(E)-tetracos-15-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[(2R)-3-hexadecanoyloxy-2-[(E)-icos-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-7-enoyl]oxypropyl] henicosanoate

C44H86NO8P (787.6090726)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadec-17-enoyloxypropan-2-yl] henicosanoate

C44H86NO8P (787.6090726)

[(2R)-3-octadecanoyloxy-2-octadec-17-enoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[(2R)-2-octadecanoyloxy-3-[(E)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-6-enoyl]oxypropyl] henicosanoate

C44H86NO8P (787.6090726)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-11-enoyl]oxypropan-2-yl] henicosanoate

C44H86NO8P (787.6090726)

[(2R)-3-octadecanoyloxy-2-[(E)-octadec-4-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[(2S)-2-dodecanoyloxy-3-[(E)-tetracos-15-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[(2R)-2-docosanoyloxy-3-[(E)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[(2R)-3-octadecanoyloxy-2-[(E)-octadec-6-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[(2R)-2-[(E)-hexadec-7-enoyl]oxy-3-icosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[(2R)-3-hexadecanoyloxy-2-[(E)-icos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[(2S)-2-decanoyloxy-3-[(E)-hexacos-5-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-9-enoyl]oxypropan-2-yl] henicosanoate

C44H86NO8P (787.6090726)

[(2S)-3-docosanoyloxy-2-[(E)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[(2R)-2-hexadecanoyloxy-3-[(E)-icos-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[(2S)-3-[(E)-docos-13-enoyl]oxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[(2R)-2-henicosanoyloxy-3-[(E)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-nonadecanoyloxypropyl] (E)-icos-11-enoate

C44H86NO8P (787.6090726)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] (E)-docos-13-enoate

C44H86NO8P (787.6090726)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-7-enoyl]oxypropan-2-yl] henicosanoate

C44H86NO8P (787.6090726)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (E)-hexacos-5-enoate

C44H86NO8P (787.6090726)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-hexadec-7-enoyl]oxypropyl] tricosanoate

C44H86NO8P (787.6090726)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-4-enoyl]oxypropan-2-yl] henicosanoate

C44H86NO8P (787.6090726)

[(2R)-2-[(E)-hexadec-9-enoyl]oxy-3-icosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[(2R)-2-octadecanoyloxy-3-[(E)-octadec-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-4-enoyl]oxypropyl] henicosanoate

C44H86NO8P (787.6090726)

[(2R)-3-[(E)-hexadec-7-enoyl]oxy-2-icosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[(2R)-2-octadecanoyloxy-3-octadec-17-enoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonadecanoyloxypropan-2-yl] (E)-icos-13-enoate

C44H86NO8P (787.6090726)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-9-enoyl]oxypropyl] henicosanoate

C44H86NO8P (787.6090726)

[(2R)-3-octadecanoyloxy-2-[(E)-octadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-11-enoyl]oxypropyl] henicosanoate

C44H86NO8P (787.6090726)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] pentacosanoate

C44H86NO8P (787.6090726)

[(2S)-3-henicosanoyloxy-2-[(E)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-heptadec-9-enoyl]oxypropan-2-yl] docosanoate

C44H86NO8P (787.6090726)

[(2R)-3-[(E)-hexadec-9-enoyl]oxy-2-icosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO8P (787.6090726)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-13-enoyl]oxypropan-2-yl] henicosanoate

C44H86NO8P (787.6090726)

2-[[(E)-2-[[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoyl]amino]-3-hydroxypentadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H80N2O6P+ (787.5753690000001)

2-[hydroxy-[(E)-3-hydroxy-2-[[(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoyl]amino]tridec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C46H80N2O6P+ (787.5753690000001)

2-[[(E)-2-[[(11Z,14Z,17Z,20Z,23Z,26Z,29Z)-dotriaconta-11,14,17,20,23,26,29-heptaenoyl]amino]-3-hydroxynon-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H80N2O6P+ (787.5753690000001)

2-[[(4E,8E)-2-[[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-3-hydroxynonadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H80N2O6P+ (787.5753690000001)

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]heptadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C46H80N2O6P+ (787.5753690000001)

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]tricosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C46H80N2O6P+ (787.5753690000001)

2-[[2-[[(8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-dotriaconta-8,11,14,17,20,23,26,29-octaenoyl]amino]-3-hydroxynonoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H80N2O6P+ (787.5753690000001)

2-[hydroxy-[3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-6,9,12,15,18,21,24,27-octaenoyl]amino]undecoxy]phosphoryl]oxyethyl-trimethylazanium

C46H80N2O6P+ (787.5753690000001)

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]amino]heptadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C46H80N2O6P+ (787.5753690000001)

2-[[(4E,8E,12E)-2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxynonadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H80N2O6P+ (787.5753690000001)

2-[hydroxy-[(E)-3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-9,12,15,18,21,24,27-heptaenoyl]amino]undec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C46H80N2O6P+ (787.5753690000001)

2-[[(4E,8E)-2-[[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoyl]amino]-3-hydroxypentadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H80N2O6P+ (787.5753690000001)

2-[[(4E,8E,12E)-2-[[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]amino]-3-hydroxypentadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C46H80N2O6P+ (787.5753690000001)

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]henicosa-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C46H80N2O6P+ (787.5753690000001)

2-[hydroxy-[(4E,8E)-3-hydroxy-2-[[(10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-10,13,16,19,22,25-hexaenoyl]amino]trideca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

C46H80N2O6P+ (787.5753690000001)

1-Stearoyl-2-oleoyl-sn-glycero-3-phosphocholine

C44H86NO8P (787.6090726)

A phosphatidylcholine 36:1 in which the phosphatidyl acyl groups at positions 1 and 2 are stearoyl and oleoyl respectively.

1-Oleoyl-2-stearoyl-sn-glycero-3-phosphocholine

C44H86NO8P (787.6090726)

A phosphatidylcholine 36:1 in which the phosphatidyl acyl groups at positions 1 and 2 are specified as oleoyl and stearoyl respectively.

PC(14:1(9Z)/22:0)

C44H86NO8P (787.6090726)

1-(9Z-hexadecenoyl)-2-eicosanoyl-glycero-3-phosphocholine

C44H86NO8P (787.6090726)

PC(20:0/16:1(9Z))

C44H86NO8P (787.6090726)

PC(22:0/14:1(9Z))

C44H86NO8P (787.6090726)

1-(11Z-eicosenoyl)-2-hexadecanoyl-glycero-3-phosphocholine

C44H86NO8P (787.6090726)

1-tetradecanoyl-2-(13Z-docosenoyl)-sn-glycero-3-phosphocholine

C44H86NO8P (787.6090726)

1-(13Z-docosenoyl)-2-tetradecanoyl-sn-glycero-3-phosphocholine

C44H86NO8P (787.6090726)

1-[(11Z)-octadecenoyl]-2-octadecanoyl-sn-glycero-3-phosphocholine

C44H86NO8P (787.6090726)

A 1-octadecanoyl-2-octadecenoyl-sn-glycero-3-phosphocholine in which the acyl groups specified at positions 1 and 2 are (11Z)-octadecenoyl and octadecanoyl respectively.

1-palmitoyl-2-(11Z-eicosenoyl)-sn-glycero-3-phosphocholine

C44H86NO8P (787.6090726)

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups specified at positions 1 and 2 are palmitoyl and (11Z)-eicosenoyl respectively.

1-Stearoyl-2-vaccenoyl-sn-glycero-3-phosphocholine

C44H86NO8P (787.6090726)

1-octadecanoyl-2-(13Z-octadecenoyl)-sn-glycero-3-phosphocholine

C44H86NO8P (787.6090726)

phosphatidylcholine 36:1

C44H86NO8P (787.6090726)

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 36 carbons in total with 1 double bond.

1-octadecanoyl-2-octadecenoyl-sn-glycero-3-phosphocholine

C44H86NO8P (787.6090726)

A phosphatidylcholine 36:1 in which the acyl groups aspecified at positions 1 and 2 are octadecanoyl and octadecenoyl (double bond at unspecified position) respectively.

PC(16:1(9Z)/20:0)

C44H86NO8P (787.6090726)

PC(20:1(11Z)/16:0)

C44H86NO8P (787.6090726)

1-octadecanoyl-2-[(11Z)-octadecenoyl]-sn-glycerophosphochlonine

C44H86NO8P (787.6090726)

A 1-octadecanoyl-2-octadecenoyl-sn-glycero-3-phosphocholine in which the acyl groups specified at positions 1 and 2 are octadecanoyl and (11Z)-octadecenoyl respectively.

PC(14:0/22:1(13Z))

C44H86NO8P (787.6090726)

PC(22:1(13Z)/14:0)

C44H86NO8P (787.6090726)

MePC(35:1)

C44H86NO8P (787.6090726)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

Hex1Cer(41:6)

C47H81NO8 (787.5961866)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

CerP(47:7)

C47H82NO6P (787.5879442)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

PC(18:1-18:0)

C44H86NO8P (787.6090726)

PANOMIX internal lipid standards

dMePE(37:1)

C44H86NO8P (787.6090726)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

DGCC 34:0;O2

C44H85NO10 (787.617315)

DGCC 36:6;O

C46H77NO9 (787.5598032)

DGCC 37:5

C47H81NO8 (787.5961866)

DGTS 36:6;O2

C46H77NO9 (787.5598032)

DGTS 37:5;O

C47H81NO8 (787.5961866)

PC O-16:0/20:2;O

C44H86NO8P (787.6090726)

PC O-18:0/18:2;O

C44H86NO8P (787.6090726)

PC O-36:2;O

C44H86NO8P (787.6090726)

PC P-18:0/18:1;O

C44H86NO8P (787.6090726)

PC 10:0_26:1

C44H86NO8P (787.6090726)

PC 12:0_24:1

C44H86NO8P (787.6090726)

PC 14:0_22:1

C44H86NO8P (787.6090726)

PC 14:1_22:0

C44H86NO8P (787.6090726)

PC 15:1_21:0

C44H86NO8P (787.6090726)

PC 16:0_20:1

C44H86NO8P (787.6090726)

PC 16:0/20:1

C44H86NO8P (787.6090726)

PC 16:1_20:0

C44H86NO8P (787.6090726)

PC 17:1_19:0

C44H86NO8P (787.6090726)

PC 18:0_18:1

C44H86NO8P (787.6090726)

PC 18:0/18:1

C44H86NO8P (787.6090726)

PC 20:0/16:1

C44H86NO8P (787.6090726)

PC 32:0/4:1

C44H86NO8P (787.6090726)

LNAPE 38:2;O

C43H82NO9P (787.5726892)

LNAPE 39:1

C44H86NO8P (787.6090726)

PE O-18:0/20:3;O2

C43H82NO9P (787.5726892)

PE O-38:3;O2

C43H82NO9P (787.5726892)

PE P-20:0/18:2;O2

C43H82NO9P (787.5726892)

PE P-20:1/18:1;O2

C43H82NO9P (787.5726892)

PE 18:0/20:2;O

C43H82NO9P (787.5726892)

PE 20:0/18:2;O

C43H82NO9P (787.5726892)

PE 20:1/18:1;O

C43H82NO9P (787.5726892)

PE 38:2;O

C43H82NO9P (787.5726892)

PE 13:0_26:1

C44H86NO8P (787.6090726)

PE 14:1_25:0

C44H86NO8P (787.6090726)

PE 15:0_24:1

C44H86NO8P (787.6090726)

PE 15:1_24:0

C44H86NO8P (787.6090726)

PE 16:1_23:0

C44H86NO8P (787.6090726)

PE 17:0_22:1

C44H86NO8P (787.6090726)

PE 17:1_22:0

C44H86NO8P (787.6090726)

PE 18:1_21:0

C44H86NO8P (787.6090726)

PE 19:0_20:1

C44H86NO8P (787.6090726)

PE 35:0/4:1

C44H86NO8P (787.6090726)

PS O-16:2/21:0

C43H82NO9P (787.5726892)

PS O-18:2/19:0

C43H82NO9P (787.5726892)

PS O-20:0/17:2

C43H82NO9P (787.5726892)

PS O-20:1/17:1

C43H82NO9P (787.5726892)

PS O-20:2/17:0

C43H82NO9P (787.5726892)

PS O-22:1/15:1

C43H82NO9P (787.5726892)

PS O-22:2/15:0

C43H82NO9P (787.5726892)

PS P-16:1/21:0

C43H82NO9P (787.5726892)

PS P-16:1/21:0 or PS O-16:2/21:0

C43H82NO9P (787.5726892)

PS P-18:1/19:0

C43H82NO9P (787.5726892)

PS P-18:1/19:0 or PS O-18:2/19:0

C43H82NO9P (787.5726892)

PS P-20:0_17:1

C43H82NO9P (787.5726892)

PS P-20:0/17:1

C43H82NO9P (787.5726892)

PS P-20:0/17:1 or PS O-20:1/17:1

C43H82NO9P (787.5726892)

PS P-20:1/17:0

C43H82NO9P (787.5726892)

PS P-20:1/17:0 or PS O-20:2/17:0

C43H82NO9P (787.5726892)

PS P-22:0/15:1

C43H82NO9P (787.5726892)

PS P-22:0/15:1 or PS O-22:1/15:1

C43H82NO9P (787.5726892)

PS P-22:1/15:0

C43H82NO9P (787.5726892)

PS P-22:1/15:0 or PS O-22:2/15:0

C43H82NO9P (787.5726892)

PS P-37:1

C43H82NO9P (787.5726892)

PS P-37:1 or PS O-37:2

C43H82NO9P (787.5726892)

GalCer 17:2;O2/24:4

C47H81NO8 (787.5961866)

GalCer 19:0;O2/22:6

C47H81NO8 (787.5961866)

GalCer 19:1;O2/22:5

C47H81NO8 (787.5961866)

GalCer 19:2;O2/22:4

C47H81NO8 (787.5961866)

GalCer 21:1;O2/20:5

C47H81NO8 (787.5961866)

GalCer 21:2;O2/20:4

C47H81NO8 (787.5961866)

GalCer 41:6;O2

C47H81NO8 (787.5961866)

GlcCer 17:2;O2/24:4

C47H81NO8 (787.5961866)

GlcCer 19:0;O2/22:6

C47H81NO8 (787.5961866)

GlcCer 19:1;O2/22:5

C47H81NO8 (787.5961866)

GlcCer 19:2;O2/22:4

C47H81NO8 (787.5961866)

GlcCer 21:1;O2/20:5

C47H81NO8 (787.5961866)

GlcCer 21:2;O2/20:4

C47H81NO8 (787.5961866)

GlcCer 41:6;O2

C47H81NO8 (787.5961866)

HexCer 17:2;O2/24:4

C47H81NO8 (787.5961866)

HexCer 19:0;O2/22:6

C47H81NO8 (787.5961866)

HexCer 19:1;O2/22:5

C47H81NO8 (787.5961866)

HexCer 19:2;O2/22:4

C47H81NO8 (787.5961866)

HexCer 21:1;O2/20:5

C47H81NO8 (787.5961866)

HexCer 21:2;O2/20:4

C47H81NO8 (787.5961866)

HexCer 41:6;O2

C47H81NO8 (787.5961866)

GDCAE 24:6

C50H77NO6 (787.5750582000001)

GLCAE 25:5

C51H81NO5 (787.6114415999999)

TLCAE 21:2

C47H81NO6S (787.5784286)

(2r)-n-[(2s,3s,4r,9z)-3,4-dihydroxy-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}docos-9-en-2-yl]-2-hydroxyhexadecanimidic acid

C44H85NO10 (787.617315)

(2s)-n-[(2r,3r,4s,9e)-3,4-dihydroxy-1-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}docos-9-en-2-yl]-2-hydroxyhexadecanimidic acid

C44H85NO10 (787.617315)

(2r)-n-[(2s,3s,4r,13z)-3,4-dihydroxy-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}docos-13-en-2-yl]-2-hydroxyhexadecanimidic acid

C44H85NO10 (787.617315)

n-[(13e)-3,4-dihydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}docos-13-en-2-yl]-2-hydroxyhexadecanimidic acid

C44H85NO10 (787.617315)

n-(3,4-dihydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}docos-9-en-2-yl)-2-hydroxyhexadecanimidic acid

C44H85NO10 (787.617315)